Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF10 line probe assay

被引:117
作者
van Doorn, LJ
Quint, W
Kleter, B
Molijn, A
Colau, B
Martin, MT
Kravang-In
Torrez-Martinez, N
Peyton, CL
Wheeler, CM
机构
[1] Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA
[2] Delft Diagnost Lab, Delft, Netherlands
[3] Glaxo Smith Kline Biol, Rixensart, Belgium
关键词
D O I
10.1128/JCM.40.3.979-983.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A comparison of two PCR-based human papillomavirus (HPV) DNA detection and genotyping systems (PGMY LBA and SPF10 LiPA) was conducted in two laboratories. Both systems are based on broad-spectrum PCR for the detection of HPV DNA, followed by reverse hybridization with type-specific probes. A total of 400 selected cervical scrape specimens in PreservCyt solution (55% normal cytology, 18% atypical squamous cells of unknown significance, 14.8% low-grade squamous intraepithelial lesions [SIL], and 12.5% high-grade SIL) were tested for the presence of HPV DNA., In this selected, group of specimens, the overall agreement between the two methods for the detection of any HPV DNA was high (kappa = 0.859). When the 20 common HPV genotypes identified by both methods were considered (HPV types 6, 11, 16, 18, 31, 33, 35, 39, 40, 42, 45, 51, 52, 53, 54, 56, 58, 59, 66, and 68), compatible genotype-specific results were observed in 96.5% of the samples, even when multiple HPV genotypes were present. However, for some specific HPV genotypes, there were significant differences in HPV detection by the two methods. PGMY LBA detected more HPV type 42 (P = 0.002), HPV type 56 (P = 0.039), and HPV type 59 (P < 0.001), whereas SPF10 LiPA detected more HPV type 31 (P < 0.001) and HPV type 52 (P = 0.031). For the remaining genotypes, including HPV types 16 and 18, the results obtained by the two methods were not significantly different. In general, both genotyping methods are highly suitable for clinical and epidemiological studies.
引用
收藏
页码:979 / 983
页数:5
相关论文
共 32 条
[21]   Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study [J].
Nobbenhuis, MAE ;
Walboomers, JMM ;
Helmerhorst, TJM ;
Rozendaal, L ;
Remmink, AJ ;
Risse, EKJ ;
van der Linden, HC ;
Voorhorst, FJ ;
Kenemans, P ;
Meijer, CJLM .
LANCET, 1999, 354 (9172) :20-25
[22]   PCR detection of human papillomavirus: Comparison between MY09/MY11 and GP5+/GP6+ primer systems [J].
Qu, WM ;
Jiang, G ;
Cruz, Y ;
Chang, CJ ;
Ho, GYF ;
Klein, RS ;
Burk, RD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (06) :1304-1310
[23]   PCR based high risk HPV testing is superior to neural network based screening for predicting incident CINIII in women with normal cytology and borderline changes [J].
Rozendaal, L ;
Westerga, J ;
van der Linden, JC ;
Walboomers, JMM ;
Voorhorst, FJ ;
Risse, EKJ ;
Boon, ME ;
Meijer, CJLM .
JOURNAL OF CLINICAL PATHOLOGY, 2000, 53 (08) :606-611
[24]   EPIDEMIOLOGIC EVIDENCE SHOWING THAT HUMAN PAPILLOMAVIRUS INFECTION CAUSES MOST CERVICAL INTRAEPITHELIAL NEOPLASIA [J].
SCHIFFMAN, MH ;
BAUER, HM ;
HOOVER, RN ;
GLASS, AG ;
CADELL, DM ;
RUSH, BB ;
SCOTT, DR ;
SHERMAN, ME ;
KURMAN, RJ ;
WACHOLDER, S ;
STANTON, CK ;
MANOS, MM .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (12) :958-964
[25]   Intratype variation in 12 human papillomavirus types: A worldwide perspective [J].
Stewart, ACM ;
Eriksson, AM ;
Manos, MM ;
Munoz, N ;
Bosch, FX ;
Peto, J ;
Wheeler, CM .
JOURNAL OF VIROLOGY, 1996, 70 (05) :3127-3136
[26]  
Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt
[27]  
12::AID-PATH431&gt
[28]  
3.0.CO
[29]  
2-F
[30]   Human papillomavirus type 16 sequence variation in cervical cancers: A worldwide perspective [J].
Yamada, T ;
Manos, MM ;
Peto, J ;
Greer, CE ;
Munoz, N ;
Bosch, FX ;
Wheeler, CM .
JOURNAL OF VIROLOGY, 1997, 71 (03) :2463-2472